Bayer faces new marathon after mammoth Monsanto merger

German chemicals and pharmaceuticals giant Bayer reported plunging profits for 2018 after taking over US agrichemical firm Monsanto, with years of hard work ahead of the group to fight off legal risks related to the merger ...

Bayer to cut 12,000 jobs after Monsanto takeover

German chemical and pharmaceutical giant Bayer said Thursday it would slash 12,000 jobs in a major restructuring following the mammoth takeover of Monsanto, enabling it to save 2.6 billion euros ($3 billion) a year from 2022.

Bayer profits plunge as Monsanto buyout bites

German chemicals and pharmaceuticals giant Bayer reported higher revenues but lower profits for the second quarter Wednesday, in its first financial statement since its mammoth takeover of US-based Monsanto.

Bayer presses on with Monsanto integration as stock suffers

German chemicals and pharmaceuticals giant Bayer said Thursday it would finally begin integrating US seeds and pesticides maker Monsanto into its business, after meeting competition authorities' final conditions for the merger.

Five things to know about Bayer and Monsanto

A cancer victim's surprise court victory over US pesticide maker Monsanto could open the floodgates to a slew of similar lawsuits, potentially leaving the firm's new German owner with a major case of buyer's remorse.

Bayer shares plunge after Monsanto cancer ruling

Shares in German chemicals and pharmaceuticals giant Bayer tumbled more than 10 percent as markets opened Monday, as investors reacted to a shock US ruling against freshly-acquired Monsanto.

page 3 from 6